NOVARTIS N (NOT MU) stock market data APIs
€115.1852
0.64(0.6%)
as of December 19, 2025
Try our APIs with
free plan!
NOVARTIS N Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NOT.MU.
Prev. Close
115.1852
Open
115.7347
High
116.0813
Low
114.9455
52 wk Range
71.4774-116.04
Market Cap
160 075 M
Dividends (Yield)
0.0488
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NOVARTIS N data using free add-ons & libraries
Get NOVARTIS N Fundamental Data
NOVARTIS N Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NOVARTIS N News
New
Trump reaches deal with 9 drug companies to lower prices
President Trump announced deals with nine major drug makers in a move to reduce pharmaceutical prices, granting a three-year break on trade tariffs if they invest more into US manufacturing. Market Do...
More Drugmakers Reach Deals With White House to Lower Prices
The companies, including Bristol-Myers Squibb, GSK and Merck, would avoid potential U.S. tariffs in return. Continue Reading
IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and bureaucratic requirements, Saxony-Anhalt is drawing a positive balance for 2025: lea...
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump
Dow Jones stock Merck struck a Most Favored Nation agreement with the Trump administration on Friday, joining other pharma bellwethers. Continue Reading
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
